Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

BridgeBio Pharma (BBIO) Shares Issued (2019 - 2025)

Historic Shares Issued for BridgeBio Pharma (BBIO) over the last 7 years, with Q3 2025 value amounting to $4.8 million.

  • BridgeBio Pharma's Shares Issued rose 2700555.56% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$262.1 million, marking a year-over-year decrease of 27167.73%. This contributed to the annual value of $38.1 million for FY2024, which is 4138.46% down from last year.
  • According to the latest figures from Q3 2025, BridgeBio Pharma's Shares Issued is $4.8 million, which was up 2700555.56% from $6.4 million recorded in Q2 2025.
  • BridgeBio Pharma's Shares Issued's 5-year high stood at $306.2 million during Q3 2023, with a 5-year trough of -$385.3 million in Q4 2023.
  • Its 5-year average for Shares Issued is $7.9 million, with a median of $3.5 million in 2021.
  • Per our database at Business Quant, BridgeBio Pharma's Shares Issued crashed by 796253.06% in 2023 and then soared by 2700555.56% in 2025.
  • BridgeBio Pharma's Shares Issued (Quarter) stood at $2.3 million in 2021, then skyrocketed by 108.6% to $4.9 million in 2022, then tumbled by 7962.53% to -$385.3 million in 2023, then grew by 28.19% to -$276.6 million in 2024, then soared by 101.75% to $4.8 million in 2025.
  • Its last three reported values are $4.8 million in Q3 2025, $6.4 million for Q2 2025, and $3.2 million during Q1 2025.